The record on rosiglitazone and the risk of myocardial infarction

N Engl J Med. 2007 Jul 5;357(1):67-9. doi: 10.1056/NEJMe078116. Epub 2007 Jun 5.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cardiovascular Diseases / chemically induced
  • Cardiovascular Diseases / mortality*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Approval
  • Drug Labeling
  • Hospitalization
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Meta-Analysis as Topic
  • Middle Aged
  • Myocardial Infarction / chemically induced*
  • Product Surveillance, Postmarketing
  • Research Design
  • Rosiglitazone
  • Thiazolidinediones / adverse effects*
  • United States

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone